M.K.B. Parmar
Impact in
-
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Reproductive Medicine top 10%
- Ovarian cancer diagnosis and treatment
Papers in
-
- Lung Cancer Treatments and Mutations 4
- Lung Cancer Diagnosis and Treatment 2
- Oncology 6
- Colorectal Cancer Treatments and Studies 3
- Cancer Treatment and Pharmacology 2
- Co-authors
- Richard Stephens (2 shared papers)Lesley Stewart (3 shared papers)R L Souhami (3 shared papers)Thierry Le Chevalier (2 shared papers)Jean‐Pierre Pignon (2 shared papers)R. Arriagada (2 shared papers)Sarah Burdett (1 shared paper)C. Le Péchoux (1 shared paper)
- Journals
- European Journal of Cancer (4 papers)Journal of Clinical Oncology (3 papers)Annals of Oncology (2 papers)Lung Cancer (2 papers)European Respiratory Journal (1 paper)
- Partner nations
- United KingdomUnited StatesIndia
In The Last Decade
M.K.B. Parmar
24 papers receiving 763 citations
M.K.B. Parmar's Hit Papers
Peers
Comparison fields: 5 of 71
- Pulmonary and Respiratory Medicine 385
- Reproductive Medicine 66
- Oncology 200
- Otorhinolaryngology 17
- Complementary and alternative medicine 32
Countries citing papers authored by M.K.B. Parmar
This map shows the geographic impact of M.K.B. Parmar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.K.B. Parmar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.K.B. Parmar more than expected).
Fields of papers citing papers by M.K.B. Parmar
This network shows the impact of papers produced by M.K.B. Parmar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.K.B. Parmar. The network helps show where M.K.B. Parmar may publish in the future.
Co-authors
The 25 scholars most cited alongside M.K.B. Parmar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data Hit paper breakdown → | 2010 | 451 |
| 2 | 2002 | 86 | |
| 3 | 2005 | 61 | |
| 4 | 2002 | 54 | |
| 5 | A combined analysis of EORTC/MRC randomized clinical trials for the prophylactic treatment of TaT1 bladder cancer. Eortc Genito-Urinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer. | 1996 | 26 |
| 6 | ICON7: Final overall survival results in the GCIG phase III randomized trial of bevacizumab in women with newly diagnosed ovarian cancer | 2013 | 21 |
| 7 | 1998 | 14 | |
| 8 | Preliminary results of a MRC randomised controlled trial of post-operative irrigation of superficial bladder cancer | 2001 | 11 |
| 9 | Randomised intercontinental trial of locoregional therapy with or without neoadjuvant chemotherapy. | 1990 | 10 |
| 10 | 1994 | 9 | |
| 11 | 2011 | 8 | |
| 12 | ICON7: FINAL OVERALL SURVIVAL RESULTS IN THE GCIG PHASE III RANDOMISED TRIAL OF BEVACIZUMAB IN NEWLY DIAGNOSED OVARIAN CANCER | 2013 | 6 |
| 13 | 1992 | 6 | |
| 14 | 2005 | 5 | |
| 15 | 2006 | 4 | |
| 16 | 2019 | 4 | |
| 17 | 2004 | 4 | |
| 18 | 1997 | 3 | |
| 19 | 2023 | 2 | |
| 20 | 2001 | 2 |
About M.K.B. Parmar
M.K.B. Parmar is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Reproductive Medicine, Surgery and Pathology and Forensic Medicine, having authored 25 papers that have together received 791 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (6 papers), Lung Cancer Treatments and Mutations (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Bladder and Urothelial Cancer Treatments (3 papers), Noise Effects and Management (2 papers), Hearing Impairment and Communication (2 papers), Cancer Treatment and Pharmacology (2 papers) and Lung Cancer Diagnosis and Treatment (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (385 citations), Reproductive Medicine (66 citations), Oncology (200 citations), Otorhinolaryngology (17 citations) and Complementary and alternative medicine (32 citations). M.K.B. Parmar has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Richard Stephens, Lesley Stewart, R L Souhami, Thierry Le Chevalier, Jean‐Pierre Pignon, R. Arriagada, Sarah Burdett, C. Le Péchoux, Hélène Tribodet and Julian P. T. Higgins. Their work appears in journals such as European Journal of Cancer, Journal of Clinical Oncology, Annals of Oncology, Lung Cancer and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.